Peter Mcnamara
Chief Scientific Officer · 8 filings · Latest: Sep 25, 2026
Tectonic Therapeutic, Inc.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
TECX | Peter Mcnamara | Chief Scientific Officer | Sep 30, 2026 | Sale | $23.04 | 536 | $12.3K | 54,305 | |
TECX | PETER MCNAMARA | — | Sep 30, 2026 | Proposed Sale | $23.34 | 493 | $11.5K | — | |
TECX | Peter Mcnamara | Chief Scientific Officer | Aug 25, 2026 | Sale | $36.52 | 43 | $1.6K | 55,285 | |
TECX | Peter Mcnamara | Chief Scientific Officer | Aug 25, 2026 | Option Exercise | $14.71 | 43 | $633 | 55,328 | |
TECX | Peter Mcnamara | Chief Scientific Officer | Aug 12, 2026 | Sale | $35.00 | 43 | $1.5K | 55,285 | |
TECX | Peter Mcnamara | Chief Scientific Officer | Aug 12, 2026 | Option Exercise | $14.71 | 43 | $633 | 55,328 | |
TECX | PETER MCNAMARA | — | Aug 12, 2026 | Proposed Sale | $31.87 | 129 | $4.1K | — | |
TECX | Peter Mcnamara | Chief Scientific Officer | Jun 30, 2026 | Sale | $35.00 | 172 | $6.0K | 55,285 | |
TECX | Peter Mcnamara | Chief Scientific Officer | Jun 30, 2026 | Option Exercise | $14.71 | 172 | $2.5K | 55,457 | |
TECX | PETER MCNAMARA | — | Jun 30, 2026 | Proposed Sale | $33.09 | 172 | $5.7K | — | |
TECX | Peter Mcnamara | Chief Scientific Officer | Mar 6, 2026 | Sale | $30.17 | 6,262 | $188.9K | 55,285 | |
TECX | Peter Mcnamara | Chief Scientific Officer | Mar 6, 2026 | Option Exercise | $3.36 | 2,715 | $9.1K | 61,547 | |
TECX | PETER MCNAMARA | — | Mar 6, 2026 | Proposed Sale | $27.85 | 6,262 | $174.4K | — | |
TECX | Peter Mcnamara | Chief Scientific Officer | Mar 4, 2026 | Sale | $25.00 | 1,650 | $41.3K | 58,832 | |
TECX | Peter Mcnamara | Chief Scientific Officer | Mar 3, 2026 | Sale | $22.06 | 1,649 | $36.4K | 37,482 | |
TECX | PETER MCNAMARA | — | Mar 4, 2026 | Proposed Sale | $24.40 | 1,650 | $40.3K | — | |
TECX | PETER MCNAMARA | — | Mar 3, 2026 | Proposed Sale | $23.00 | 1,649 | $37.9K | — |